Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |